The executive answer
What is the new enterprise buying map?
The New Enterprise Buying Map™ is a RISE framework for understanding the six constituencies that shape a consequential organizational purchase: business and strategy, medical and clinical, economic and procurement, technology and data, governance and risk, and implementation and adoption. At the center is an alignment architect who helps the network build a shared case for action.
Enterprise opportunities do not advance because one person is persuaded. They advance when a network resolves different questions about value, risk, feasibility and change—and those answers become coherent enough for the organization to commit.
The old map no longer describes the decision
Traditional commercial models often begin with a buyer, an economic decision-maker and a linear sequence of influence. That model is increasingly incomplete for complex life sciences decisions.
A platform, partner, data capability, commercialization service or new operating model can touch clinical credibility, regulatory exposure, enterprise technology, procurement policy, budget priorities and the daily work of multiple teams. Each constituency sees a different decision because each carries a different consequence if the organization gets it wrong.
What each constituency must resolve
Business + Strategy
Is this important enough to act on now?Strategic relevance, urgency, executive priority and measurable business impact.
Medical + Clinical
Is the decision credible and valuable in the clinical context?Evidence quality, scientific integrity, patient impact and medical relevance.
Economic + Procurement
Is the investment justified and commercially sound?Budget ownership, economic value, pricing, terms and vendor comparability.
Technology + Data
Can this work safely inside the enterprise?Integration, architecture, privacy, cybersecurity, data quality and scalability.
Governance + Risk
Can the organization defend this decision?Legal, regulatory, compliance, brand and operational risk requirements.
Implementation + Adoption
Can people absorb the change and realize the value?Workflow fit, ownership, capability, capacity, change and sustained adoption.
The alignment architect is the connective role
The internal champion is often described as the person who believes in the solution. Belief is useful, but it is not enough. Complex decisions require someone who can translate value across constituencies, surface unresolved risk, sequence the right conversations and connect separate requirements into one defensible case.
RISE calls this person the alignment architect. The role may be held by a senior sponsor, transformation leader, functional executive or respected operator. What matters is not the title. What matters is the person’s ability to make the decision easier for the enterprise to understand and safer for the enterprise to make.
How to build the map around a real opportunity
- Define the consequential decision.Name the commitment the customer must make—not the meeting, proposal or activity your team wants next.
- Identify the six constituencies.Map named people where known, but do not leave a required role blank merely because access has not yet been established.
- Document each group’s governing question.Clarify the outcome it values, the risk it carries, the evidence it trusts and the condition that would prevent support.
- Trace the dependencies.Show which answer, approval or proof must exist before another constituency can move.
- Equip the alignment architect.Create a shared case for action that the internal leader can carry credibly across the network.
Signals that the commercial team is using the old map
- The opportunity is described primarily through one senior relationship.
- Stakeholders appear only when they create an objection.
- One presentation is expected to work across every audience.
- Procurement, technology or compliance is treated as a final-stage hurdle.
- Implementation ownership is discussed after approval rather than before it.
- The internal champion is supportive but cannot explain how the organization will decide.
Use the map
See the buying coalition as a system.
Download the one-page New Enterprise Buying Map™ for account strategy, opportunity reviews and executive conversations.
Download the executive map One-page PDF · Complimentary RISE resourceFrequently asked questions
The enterprise buying network, clarified
What is an enterprise buying map?
An enterprise buying map shows the constituencies that shape a complex organizational purchase, the questions each group must resolve and the dependencies that connect their decisions. It replaces the idea of one buyer with a network view of commitment.
Who is involved in a life sciences enterprise buying decision?
The coalition commonly includes business and strategy leaders, medical or clinical stakeholders, finance and procurement, technology and data teams, legal and compliance, implementation owners and an internal leader who creates alignment.
How is a buying map different from an org chart?
An org chart shows reporting relationships. A buying map shows decision influence, required evidence, perceived risk, implementation dependency and the path by which a group becomes ready to act.
How does the Buying Map relate to the RISE Decision Landscape?
The New Enterprise Buying Map identifies the constituencies around a consequential purchase. The RISE Decision Landscape then tests whether authority, blockers, adoption owners, required beliefs and internal alignment are sufficiently clear.
When should a commercial team build the map?
Build it during account and opportunity strategy, before a proposal becomes the primary sales tool. Update it whenever a new stakeholder, risk requirement, budget issue or implementation dependency changes the decision.
Redraw the buying map
If an important opportunity is relying on an old picture of the customer, RISE can help your team map the network and find the next credible move.
Talk with Carl